×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Session 6C: Comparability Biologicals
Session Chair(s)
Anthony Ridgway, PhD
Acting Director, Biologics and Genetic Therapies Directorate
Health Canada, Canada
Speaker(s)
An Industrial View of Comparability Applied to Biopharmaceuticals
Anthony S Lubiniecki
Janssen R&D LLC, United States
Senior Scientific Director & Fellow
FDA Perspective
Linan Ha
FDA, United States
Team Leader, Division of Biotechnology Review & Research I, OBP, OPQ, CDER
European Perspective
Kowid Ho, PharmD
F. Hoffmann-La Roche Ltd, Switzerland
Pharma Technical Regulatory Policy
Have an account?